MX2016016746A - Composiciones de vacuna con adyuvante dual, preparacion y usos. - Google Patents

Composiciones de vacuna con adyuvante dual, preparacion y usos.

Info

Publication number
MX2016016746A
MX2016016746A MX2016016746A MX2016016746A MX2016016746A MX 2016016746 A MX2016016746 A MX 2016016746A MX 2016016746 A MX2016016746 A MX 2016016746A MX 2016016746 A MX2016016746 A MX 2016016746A MX 2016016746 A MX2016016746 A MX 2016016746A
Authority
MX
Mexico
Prior art keywords
preparation
vaccine compositions
adjuvant vaccine
dual adjuvant
dual
Prior art date
Application number
MX2016016746A
Other languages
English (en)
Inventor
H Ruehling Roger
Ford Brianna
Original Assignee
Biomune Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomune Company filed Critical Biomune Company
Publication of MX2016016746A publication Critical patent/MX2016016746A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0275—Salmonella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Abstract

La presente invención se refiere a vacunas que comprenden una cantidad eficaz de al menos un antígeno en una emulsión de agua en aceite en agua (WOW) y un adyuvante adicional, y a los métodos de preparación y usos de las mismas.
MX2016016746A 2014-06-16 2015-06-15 Composiciones de vacuna con adyuvante dual, preparacion y usos. MX2016016746A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14/305,329 US20150359880A1 (en) 2014-06-16 2014-06-16 Dual adjuvant vaccine compositions, preparation and uses
PCT/US2015/035742 WO2015195504A1 (en) 2014-06-16 2015-06-15 Dual adjuvant vaccine compositions, preparation and uses

Publications (1)

Publication Number Publication Date
MX2016016746A true MX2016016746A (es) 2017-07-11

Family

ID=53499085

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016016746A MX2016016746A (es) 2014-06-16 2015-06-15 Composiciones de vacuna con adyuvante dual, preparacion y usos.

Country Status (10)

Country Link
US (2) US20150359880A1 (es)
EP (1) EP3154575A1 (es)
JP (1) JP2017518338A (es)
CN (1) CN107073097A (es)
BR (1) BR112016029513A2 (es)
MX (1) MX2016016746A (es)
PE (1) PE20170243A1 (es)
RU (1) RU2729646C2 (es)
WO (1) WO2015195504A1 (es)
ZA (1) ZA201608487B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8680390B2 (en) 2009-10-16 2014-03-25 Kesumo Llc Foot-operated controller
US9076419B2 (en) 2012-03-14 2015-07-07 Bebop Sensors, Inc. Multi-touch pad controller
US10362989B2 (en) 2014-06-09 2019-07-30 Bebop Sensors, Inc. Sensor system integrated with a glove
US9827996B2 (en) 2015-06-25 2017-11-28 Bebop Sensors, Inc. Sensor systems integrated with steering wheels
JP2019001770A (ja) * 2017-06-15 2019-01-10 エス・ピー・ジーテクノ株式会社 乳化型ワクチン製剤とその生成用デバイス
US10884496B2 (en) 2018-07-05 2021-01-05 Bebop Sensors, Inc. One-size-fits-all data glove
CN109663125A (zh) * 2019-01-30 2019-04-23 山东省农业科学院畜牧兽医研究所 一种鸡肠炎沙门氏菌灭活疫苗及其应用
US11480481B2 (en) 2019-03-13 2022-10-25 Bebop Sensors, Inc. Alignment mechanisms sensor systems employing piezoresistive materials
CN115253736A (zh) * 2022-07-21 2022-11-01 苏州逻晟生物医药有限公司 一种新的抗原乳化方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4069313A (en) * 1974-11-19 1978-01-17 Merck & Co., Inc. Water-in-oil adjuvant composition
FR2649012B1 (fr) * 1989-07-03 1991-10-25 Seppic Sa Emulsions multiphasiques injectables
US5622649A (en) * 1991-06-27 1997-04-22 Emory University Multiple emulsions and methods of preparation
EP0640348A1 (en) 1993-07-26 1995-03-01 Akzo Nobel N.V. Oil-based and water-based adjuvant mixture
US5817320A (en) * 1994-06-20 1998-10-06 The United States Of America As Represented By The Secretary Of The Agriculture In ovo immunization of avian embryos with oil-emulsion vaccines
JPH11269093A (ja) * 1998-01-22 1999-10-05 Shionogi & Co Ltd 油性アジュバントワクチン製剤
US20020051748A1 (en) * 1998-12-22 2002-05-02 William C. Snow Stabilized water-in-oil-in-water antigen delivery system
JP2001131087A (ja) * 1999-11-05 2001-05-15 Chemo Sero Therapeut Res Inst オイルアジュバントワクチン
JP2002080396A (ja) * 2000-09-06 2002-03-19 Nippon Inst For Biological Science 鶏用ワクチン製剤
ES2258108T3 (es) 2000-11-07 2006-08-16 Immunovaccine Technologies Inc. Vacunas con respuesta inmune mejorada y procedimientos de preparacion de las mismas.
CA2528007C (en) * 2003-06-02 2012-03-27 Chiron Corporation Immunogenic compositions based on microparticles comprising adsorbed toxoid and a polysaccharide-containing antigen
US7691368B2 (en) * 2005-04-15 2010-04-06 Merial Limited Vaccine formulations
EP1951299B1 (en) * 2005-11-04 2012-01-04 Novartis Vaccines and Diagnostics S.r.l. Influenza vaccines including combinations of particulate adjuvants and immunopotentiators
UA100370C2 (uk) * 2006-12-11 2012-12-25 Мериал Лимитед Спосіб вакцинації птахів проти salmonella
JP2009215226A (ja) * 2008-03-11 2009-09-24 Chemo Sero Therapeut Res Inst 動物用不活化サルモネラ３価ワクチンおよびその調製方法
US20110280949A1 (en) * 2008-08-06 2011-11-17 Padma Malyala Microparticles for use in immunogenic compositions
US20110052633A1 (en) * 2009-09-02 2011-03-03 National Health Research Institutes Multi-phase emulsions based on amphiphilic block copolymers
WO2012092226A1 (en) 2010-12-27 2012-07-05 Biomune Company Veterinary vaccine composition against infections caused by salmonella
CN103223164B (zh) * 2013-04-15 2014-08-20 华南农业大学 一种水包油包水型佐剂疫苗及其制备方法

Also Published As

Publication number Publication date
RU2729646C2 (ru) 2020-08-11
JP2017518338A (ja) 2017-07-06
ZA201608487B (en) 2018-05-30
US20150359880A1 (en) 2015-12-17
RU2017101091A3 (es) 2018-12-18
PE20170243A1 (es) 2017-04-19
BR112016029513A2 (pt) 2017-08-22
US10772954B2 (en) 2020-09-15
US20170196972A1 (en) 2017-07-13
EP3154575A1 (en) 2017-04-19
WO2015195504A1 (en) 2015-12-23
CN107073097A (zh) 2017-08-18
RU2017101091A (ru) 2018-07-16

Similar Documents

Publication Publication Date Title
HUS2200035I1 (hu) Konjugált burokszaccharid antigéneket tartalmazó immunogén készítmények és alkalmazásaik
MX2016016746A (es) Composiciones de vacuna con adyuvante dual, preparacion y usos.
MX2017001406A (es) Agentes a base de flagelina y usos de los mismos, incluyendo vacunación efectiva.
EP3012322A4 (en) GENEELED STRAIN VARIANT OF PORCINE PSEUDORABIES VIRUS, VACCINE COMPOSITION, PROCESS FOR THE PREPARATION THEREOF AND USE THEREOF
AP2016009664A0 (en) Attenuated african swine fever virus vaccine
MX2022002106A (es) Formulaciones de vacuna de vial unico.
PH12018000197A1 (en) Hand, foot, and mouth vaccines and methods of manufacture and use thereof
EP3200831A4 (en) Vaccines having an antigen and interleukin-21 as an adjuvant
MX2017002803A (es) Coronavirus bovino atenuado y vacunas relacionadas.
PH12015501716B1 (en) Anti-mycoplasma spp. subunit vaccine
MX2020005584A (es) Vacunacion con particulas de replicon y adyuvante oleoso.
MX2022013912A (es) Procedimientos novedosos para inducir una respuesta inmunitaria.
MX2017006744A (es) Composiciones adyuvantes y metodos relacionados.
MX2015015428A (es) Eliminacion de riesgo de narcolepsia en vacunas contra influenza.
EA201690378A1 (ru) Вакцинные композиции против наркотической зависимости
IL259451A (en) Live virus with accumulation of dengue fever of a weakened nature and vaccination of dengue fever containing identical antigens